NCT06481033

Brief Summary

Few treatments target core features of suicidal thoughts and behaviors in Veterans. Real-time functional magnetic resonance imaging neurofeedback can provide information regarding brain activation associated with suicide-specific rumination, defined as a "repetitive mental fixation on one's suicidal thoughts and intentions." The goal of this feasibility study is for Veterans to learn strategies for modulating activity within brain regions that have been demonstrated to contribute to the maintenance of rumination, as they receive neurofeedback feedback signals from the brain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable depression

Timeline
7mo left

Started Aug 2024

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Aug 2024Dec 2026

First Submitted

Initial submission to the registry

June 17, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

June 17, 2024

Last Update Submit

July 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Acceptability and Feasibility

    The Client Satisfaction Questionnaire will be used to assess acceptability and feasibility of implementing real-time fMRI neurofeedback in a Veteran population. The total score on the questionnaire ranges from from 8 to 32 with higher scores indicative of greater satisfaction.

    Total score obtained 2 weeks following first real-time fMRI neurofeedback session.

Secondary Outcomes (1)

  • Suicide Rumination Scale

    Change in total score from pre-treatment to post-treatment (2 weeks).

Study Arms (1)

Real-time fMRI Neurofeedback

EXPERIMENTAL

This is a pilot study to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging feedback for veterans experiencing suicide-specific rumination. All study participants will receive the intervention.

Behavioral: Real Time fMRI Neurofeedback

Interventions

The proposed pilot study is designed to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging (rt-fMRI) feedback in reducing suicide-specific rumination in veterans. Fifteen veterans will receive 2 rt-fMRI neurofeedback sessions while attempting to alter connectivity in brain regions that play a role in rumination. Pre- and post-treatment assessments of suicide, disability, functional impairment, and quality of life will be collected.

Real-time fMRI Neurofeedback

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • U.S. military veteran between 18-65 years old
  • negative pregnancy test on MRI scan days
  • score greater than or equal to 10 on the Suicide Rumination Scale
  • clinically stabilized on psychotropic medications
  • engaged in mental health care treatment
  • able to provide written, informed consent

You may not qualify if:

  • no major medical or neurological disorders that could interfere with treatment
  • moderate or severe traumatic brain injury
  • current imminent suicide risk, as determined through psychiatric interview, responses to C-SSRS, and clinical judgment of the assessor
  • any current psychotic disorder
  • MRI contraindications
  • any substance use disorder for substances other than cannabis or alcohol (mild alcohol or cannabis use disorder does not exclude participants but moderate or severe alcohol or cannabis substance use disorder is disqualifying)
  • pregnant or trying to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James J. Peters VA Medical Center, Bronx, NY

The Bronx, New York, 10468-3904, United States

RECRUITING

MeSH Terms

Conditions

DepressionSuicideMood Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSelf-Injurious BehaviorMental Disorders

Study Officials

  • Philip R Szeszko, PhD

    James J. Peters Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Philip R Szeszko, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The goal of this study is to collect feasibility and acceptability data regarding the utility of using real-time functional magnetic resonance imaging neurofeedback in veterans experiencing suicide-specific rumination defined as a "repetitive mental fixation on one's suicidal thoughts and intentions." Veterans will be provided neurofeedback signals from the brain to identify mental strategies for altering brain connectivity to reduce rumination. Pre- and post-treatment assessments of suicide, disability, functional impairment, and quality of life will be collected.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2024

First Posted

July 1, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The investigators will obtain IRB approval prior to sharing de-identified data.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Data will be shared with scientific collaborators after the data have been analyzed and submitted for publication.
Access Criteria
De-identified data will be shared when the study is completed and following IRB approval.

Locations